Who Buys Dasatinib from India — 177 Importers Behind a $16.4M Market
India's dasatinib import market is served by 177 active buyers who collectively imported $16.4M across 508 shipments. TARO PHARMACEUTICALS INC (CANADA) leads with a 16.0% market share, followed by MSN LIFE CARE SA DE CVRFC MLC170629 and DR REDDYS LABORARORIES, INC. The top 5 buyers together control 54.3% of total import value, reflecting a moderately competitive buyer landscape.
Dasatinib buyer data — 177 importers · $16.4M market · 508 shipmentsTransData Nexus · Indian Customs Data
Top Dasatinib Importers — Ranked by Import Value
TARO PHARMACEUTICALS INC (CANADA) is the leading dasatinib importer from India, holding a 16.0% share of the $16.4M market across 508 shipments from 177 buyers. The top 5 buyers — TARO PHARMACEUTICALS INC (CANADA), MSN LIFE CARE SA DE CVRFC MLC170629 (MEXICO), DR REDDYS LABORARORIES, INC (UNITED STATES), AUROBINDO PHARMA USA INC (UNITED STATES), DR REDDYS LABORATORIES INC (UNITED STATES) — collectively control 54.3% of total import value.
Top Dasatinib Buyers & Importers
Ranked by import value · 177 active buyers · Indian Customs (DGFT) data
Mar 2026
Top Dasatinib Buyers & Importers — Ranked by Import Value. 177 active buyers with import value, shipments, country and supplier data compiled from Indian Customs records by TransData Nexus.
Which companies are buying Dasatinib — and from which countries?
Flow of Dasatinib exports from India: each country's share and the named importers behind the numbers
Dasatinib — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Top 5 importing countries account for 80.9% of global Dasatinib imports — led by United States (31.7%) with a total trade value of $16.4M across 508 shipments from India.
Market Analysis: Top Importing Countries & Their Importers
1United States
United States emerges as the first largest importing country, achieving a total trade value of $5.2M through 21 shipments. This represents a market share of 31.7% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United States has a diverse importer base, with their top importers including:
• DR REDDYS LABORARORIES, INC - $1.6M (30.9% of country's total business)
• AUROBINDO PHARMA USA INC - $1.6M (30.0% of country's total business)
• DR REDDYS LABORATORIES INC - $1.4M (27.1% of country's total business)
• AUROBINDO PHARMA USA., INC, - $617.6K (11.9% of country's total business)
Key Insight: United States demonstrates strong market positioning with an average shipment value of $247.4K, indicating premium pricing strategy compared to the market average of $32.3K.
United States is a key market for Dasatinib imports, representing 31.7% of total trade value.
The importation of Dasatinib from India involves various buyer segments, each with distinct purchasing behaviors:
Pharmaceutical Companies: Entities like TARO PHARMACEUTICALS INC (Canada), DR. REDDY'S LABORATORIES INC (United States), and AUROBINDO PHARMA USA INC (United States) are prominent buyers. These companies procure Dasatinib to expand their oncology portfolios, ensuring a steady supply to meet market demand. Their purchasing patterns typically involve large, consistent orders to maintain inventory levels and fulfill contractual obligations.
Distributors: Organizations such as YUSEN LOGISTICS BENELUX BELGIUM (Belgium) function as intermediaries, facilitating the distribution of Dasatinib to various healthcare providers. Their procurement is characterized by bulk purchases, aligning with market demand and distribution agreements.
Healthcare Providers: Entities like SUN PHARMA ANZ PTY LTD (Australia) may represent hospital groups or healthcare networks that import Dasatinib directly to ensure timely availability for patient treatment. Their buying behavior is influenced by patient needs, treatment protocols, and budget considerations, often resulting in periodic, substantial orders.
Import regulations for Dasatinib vary across the top importing countries:
United States:
Regulatory Authority: Food and Drug Administration (FDA).
Import Registration Process: Importers must ensure that Dasatinib complies with FDA regulations, including proper labeling and registration. Affirmation of Compliance codes, such as Drug Registration Number (REG) and Drug Listing Number (DLS), are required to facilitate the import process.
Estimated Timeline for Registration: The timeline can vary; however, providing accurate Affirmation of Compliance codes can expedite the initial screening and review process.
Import Tariff/Duty for HS 30049049: Specific tariff rates for this HS code should be verified with the U.S. International Trade Commission or Customs and Border Protection, as they are subject to change.
The demand for Dasatinib in importing countries is influenced by several factors:
Disease Prevalence: Dasatinib is primarily used to treat chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). The prevalence of these conditions directly impacts demand. For instance, the American Cancer Society estimated that in 2025, approximately 8,450 new cases of CML would be diagnosed in the United States, indicating a steady need for effective treatments like Dasatinib.
Government Healthcare Programs and Universal Health Coverage Expansion: Countries expanding universal health coverage and enhancing oncology treatment programs contribute to increased demand. For example, Australia's Pharmaceutical Benefits Scheme (PBS) subsidizes medications like Dasatinib, making them more accessible to patients and thereby driving demand.
WHO Essential Medicines List Procurement and Tender-Based Purchasing: Dasatinib's inclusion in the World Health Organization's List of Essential Medicines underscores its importance in cancer treatment. This designation encourages procurement by government and international health organizations through tender-based purchasing, ensuring broader access and consistent demand.
With 177 buyers across 71 countries, the global market for Dasatinib reflects a robust and diverse demand landscape, presenting significant opportunities for suppliers to meet the needs of various healthcare systems.
Common Questions — Dasatinib Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest dasatinib buyer importing from India?
Based on import volume and value, TARO PHARMACEUTICALS INC (CANADA) leads with $2.6M in imports and a 16.0% market share — the highest of any single dasatinib importer. MSN LIFE CARE SA DE CVRFC MLC170629 (MEXICO) and DR REDDYS LABORARORIES, INC (UNITED STATES) are the next largest buyers.
QHow many companies buy dasatinib from India?
There are 177 active dasatinib buyers importing from India, with a combined market of $16.4M across 508 shipments to 71 countries. The top 5 buyers hold 54.3% of total import value, while the remaining 172 buyers handle the other 45.7%.
QWhich countries import the most dasatinib from India?
The top importing countries for dasatinib from India are United States (31.7%), Canada (20.1%), Australia (12.9%), Mexico (10.4%), Belgium (5.8%). These markets represent the largest demand centres for Indian pharmaceutical exports of dasatinib, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for dasatinib from India?
The average import transaction value for dasatinib from India is $32.3K, with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
The importation of Dasatinib from India involves various buyer segments, each with distinct purchasing behaviors:
Pharmaceutical Companies: Entities like TARO PHARMACEUTICALS INC (Canada), DR. REDDY'S LABORATORIES INC (United States), and AUROBINDO PHARMA USA INC (United States) are prominent buyers. These companies procure Dasatinib to expand their oncology portfolios, ensuring a steady supply to meet market demand. Their purchasing patterns typically involve large, consistent orders to maintain inventory levels and fulfill contractual obligations.
Distributors: Organizations such as YUSEN LOGISTICS BENELUX BELGIUM (Belgium) function as intermediaries, facilitating the distribution of Dasatinib to various healthcare providers. Their procurement is characterized by bulk purchases, aligning with market demand and distribution agreements.
Healthcare Providers: Entities like SUN PHARMA ANZ PTY LTD (Australia) may represent hospital groups or healthcare networks that import Dasatinib directly to ensure timely availability for patient treatment. Their buying behavior is influenced by patient needs, treatment protocols, and budget considerations, often resulting in periodic, substantial orders.
Import regulations for Dasatinib vary across the top importing countries:
United States:
Regulatory Authority: Food and Drug Administration (FDA).
Import Registration Process: Importers must ensure that Dasatinib complies with FDA regulations, including proper labeling and registration. Affirmation of Compliance codes, such as Drug Registration Number (REG) and Drug Listing Number (DLS), are required to facilitate the import process.
Estimated Timeline for Registration: The timeline can vary; however, providing accurate Affirmation of Compliance codes can expedite the initial screening and review process.
Import Tariff/Duty for HS 30049049: Specific tariff rates for this HS code should be verified with the U.S. International Trade Commission or Customs and Border Protection, as they are subject to change.
The demand for Dasatinib in importing countries is influenced by several factors:
Disease Prevalence: Dasatinib is primarily used to treat chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). The prevalence of these conditions directly impacts demand. For instance, the American Cancer Society estimated that in 2025, approximately 8,450 new cases of CML would be diagnosed in the United States, indicating a steady need for effective treatments like Dasatinib.
Government Healthcare Programs and Universal Health Coverage Expansion: Countries expanding universal health coverage and enhancing oncology treatment programs contribute to increased demand. For example, Australia's Pharmaceutical Benefits Scheme (PBS) subsidizes medications like Dasatinib, making them more accessible to patients and thereby driving demand.
WHO Essential Medicines List Procurement and Tender-Based Purchasing: Dasatinib's inclusion in the World Health Organization's List of Essential Medicines underscores its importance in cancer treatment. This designation encourages procurement by government and international health organizations through tender-based purchasing, ensuring broader access and consistent demand.
With 177 buyers across 71 countries, the global market for Dasatinib reflects a robust and diverse demand landscape, presenting significant opportunities for suppliers to meet the needs of various healthcare systems.
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Canada emerges as the second largest importing country, achieving a total trade value of $3.3M through 21 shipments. This represents a market share of 20.1% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Canada has a diverse importer base, with their top importers including:
• TARO PHARMACEUTICALS INC - $2.6M (79.8% of country's total business)
• DR REDDYS LABORATORIES CANADA INC - $363.3K (11.1% of country's total business)
• DR. REDDYS LABORATORIES CANADA INC - $300.6K (9.1% of country's total business)
Key Insight: Canada demonstrates strong market positioning with an average shipment value of $156.5K, indicating premium pricing strategy compared to the market average of $32.3K.
Canada is a key market for Dasatinib imports, representing 20.1% of total trade value.
Primary Market
Secondary Market
3Australia
Australia emerges as the third largest importing country, achieving a total trade value of $2.1M through 17 shipments. This represents a market share of 12.9% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Australia has a diverse importer base, with their top importers including:
• SUN PHARMA ANZ PTY LTD. - $682.5K (32.2% of country's total business)
• SUN PHARMA ANZ PTY LTD - $678.4K (32.0% of country's total business)
• DR REDDYS LABORATORIES (AUSTRALIA) - $364.5K (17.2% of country's total business)
• DR.REDDY'S LABORATORIES (AUSTRALIA) - $248.0K (11.7% of country's total business)
Key Insight: Australia demonstrates strong market positioning with an average shipment value of $124.7K, indicating premium pricing strategy compared to the market average of $32.3K.
Australia is a key market for Dasatinib imports, representing 12.9% of total trade value.
Primary Market
Secondary Market
4Mexico
Mexico emerges as the fourth largest importing country, achieving a total trade value of $1.7M through 8 shipments. This represents a market share of 10.4% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Mexico has a diverse importer base, with their top importers including:
• MSN LIFE CARE SA DE CVRFC MLC170629 - $1.7M (99.8% of country's total business)
Key Insight: Mexico demonstrates strong market positioning with an average shipment value of $212.3K, indicating premium pricing strategy compared to the market average of $32.3K.
Mexico is a key market for Dasatinib imports, representing 10.4% of total trade value.
Primary Market
Secondary Market
5Belgium
Belgium emerges as the fifth largest importing country, achieving a total trade value of $947.7K through 11 shipments. This represents a market share of 5.8% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Belgium has a diverse importer base, with their top importers including:
• YUSEN LOGISTICS BENELUX BELGIUM - $947.7K (100.0% of country's total business)
Key Insight: Belgium demonstrates strong market positioning with an average shipment value of $86.2K, indicating premium pricing strategy compared to the market average of $32.3K.
Belgium is a key market for Dasatinib imports, representing 5.8% of total trade value.
Primary Market
Secondary Market
Government Procurement Agencies: Organizations such as NUEVOS ETICOS NEOETHICALS S A (Guatemala) may engage in tender-based purchasing to supply public healthcare systems. Their procurement processes are typically governed by national healthcare policies, budget allocations, and the objective of providing affordable medications to the population.
Understanding these segments is crucial for tailoring market strategies, forecasting demand, and ensuring efficient supply chain management.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Regulatory Authority: Health Canada.
Import Registration Process: Importers must comply with the Food and Drug Regulations, ensuring that Dasatinib is authorized for sale in Canada. In cases of drug shortages, Health Canada may permit exceptional importation and sale of designated drugs.
Estimated Timeline for Registration: Timelines can vary; during shortages, the exceptional importation process may expedite access.
Import Tariff/Duty for HS 30049049: Import duties for pharmaceuticals are generally low or exempt; specific rates should be confirmed with the Canada Border Services Agency.
Import Registration Process: Dasatinib must be registered in the Australian Register of Therapeutic Goods (ARTG). Importers need to provide evidence of compliance with TGA standards, including quality, safety, and efficacy.
Estimated Timeline for Registration: The registration process can take several months, depending on the completeness of the application and TGA's assessment workload.
Import Tariff/Duty for HS 30049049: Pharmaceuticals are typically subject to low tariffs; exact rates should be verified with the Australian Border Force.
Mexico:
Regulatory Authority: Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS).
Import Registration Process: Importers must obtain a sanitary registration from COFEPRIS, demonstrating that Dasatinib meets Mexican health regulations.
Estimated Timeline for Registration: The process can take several months, influenced by the complexity of the application and COFEPRIS's review schedule.
Import Tariff/Duty for HS 30049049: Tariff rates should be confirmed with the Mexican Tax Administration Service (SAT), as they may vary.
Belgium:
Regulatory Authority: Federal Agency for Medicines and Health Products (FAMHP).
Import Registration Process: Dasatinib must be authorized for the Belgian market, requiring compliance with FAMHP regulations, including quality, safety, and efficacy standards.
Estimated Timeline for Registration: The registration process can take several months, depending on the application details and FAMHP's review process.
Import Tariff/Duty for HS 30049049: As part of the European Union, Belgium applies the EU's Common External Tariff; specific rates should be verified with Belgian Customs.
Importers are advised to consult the respective regulatory authorities and customs agencies for the most current and detailed information.
TransData Nexus Research · Government and regulatory sourcesMar 2026
TransData Nexus Research · Government and regulatory sourcesMar 2026
$71.99 per unit
Government Procurement Agencies: Organizations such as NUEVOS ETICOS NEOETHICALS S A (Guatemala) may engage in tender-based purchasing to supply public healthcare systems. Their procurement processes are typically governed by national healthcare policies, budget allocations, and the objective of providing affordable medications to the population.
Understanding these segments is crucial for tailoring market strategies, forecasting demand, and ensuring efficient supply chain management.
TransData Nexus Research · Government and regulatory sourcesMar 2026
Regulatory Authority: Health Canada.
Import Registration Process: Importers must comply with the Food and Drug Regulations, ensuring that Dasatinib is authorized for sale in Canada. In cases of drug shortages, Health Canada may permit exceptional importation and sale of designated drugs.
Estimated Timeline for Registration: Timelines can vary; during shortages, the exceptional importation process may expedite access.
Import Tariff/Duty for HS 30049049: Import duties for pharmaceuticals are generally low or exempt; specific rates should be confirmed with the Canada Border Services Agency.
Import Registration Process: Dasatinib must be registered in the Australian Register of Therapeutic Goods (ARTG). Importers need to provide evidence of compliance with TGA standards, including quality, safety, and efficacy.
Estimated Timeline for Registration: The registration process can take several months, depending on the completeness of the application and TGA's assessment workload.
Import Tariff/Duty for HS 30049049: Pharmaceuticals are typically subject to low tariffs; exact rates should be verified with the Australian Border Force.
Mexico:
Regulatory Authority: Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS).
Import Registration Process: Importers must obtain a sanitary registration from COFEPRIS, demonstrating that Dasatinib meets Mexican health regulations.
Estimated Timeline for Registration: The process can take several months, influenced by the complexity of the application and COFEPRIS's review schedule.
Import Tariff/Duty for HS 30049049: Tariff rates should be confirmed with the Mexican Tax Administration Service (SAT), as they may vary.
Belgium:
Regulatory Authority: Federal Agency for Medicines and Health Products (FAMHP).
Import Registration Process: Dasatinib must be authorized for the Belgian market, requiring compliance with FAMHP regulations, including quality, safety, and efficacy standards.
Estimated Timeline for Registration: The registration process can take several months, depending on the application details and FAMHP's review process.
Import Tariff/Duty for HS 30049049: As part of the European Union, Belgium applies the EU's Common External Tariff; specific rates should be verified with Belgian Customs.
Importers are advised to consult the respective regulatory authorities and customs agencies for the most current and detailed information.
TransData Nexus Research · Government and regulatory sourcesMar 2026
TransData Nexus Research · Government and regulatory sourcesMar 2026
Analysis Methodology
1.Buyer Identification: 177 global importers of Dasatinib identified from consignee fields in DGFT shipping bill records.
2.Import Value Analysis: Total import value aggregated from 508 individual shipping bill records. Values are FOB in USD.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
4.Geographic Distribution: Buyer imports distributed across 71 destination countries with market share per buyer calculated from capped values.
